Skip to main content

and
  1. No Access

    Article

    A new immunodeficiency disorder in humans involving NK cells

    Immunodeficiency disorders have provided much information on the development and interaction of the various B and T lymphoid components in the immune system of man. As the lymphoid system becomes increasingly ...

    John C. Roder, Tina Haliotis, Margareta Klein, Stefan Korec, James R. Jett in Nature (1980)

  2. No Access

    Article

    Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

    THE human T-lymphotropic virus type I (HTLV-I), the first human retrovirus to be characterized, is associated with adult T-cell leukaemia and a chronic progressive disease of the central nervous system termed ...

    Steven Jacobson, Hisatoshi Shida, Dale E. McFarlin, Anthony S. Fauci in Nature (1990)

  3. No Access

    Article

    HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

    PRIMARY infection with the human immunodeficiency virus (HIV) is generally followed by a burst of viraemia with or without clinical symptoms1–3. This in turn is followed by a prolonged period of clinical latency....

    Giuseppe Pantaleo, Cecilia Graziosi, James F. Demarest, Luca Butini in Nature (1993)

  4. No Access

    Article

    Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV

    A SIGNIFICANT proportion (up to 70%) of individuals experience an acute clinical syndrome of varying severity associated with primary infection with the human immunodeficiency virus (HIV)1–4. We report here studi...

    Giuseppe Pantaleo, James F. Demarest, Hugo Soudeyns, Cecilia Graziosi in Nature (1994)

  5. No Access

    Article

    Trapped but still dangerous

    Lewis K. Schrager, Anthony S. Fauci in Nature (1995)

  6. Article

    An elusive soluble suppressor

    Anthony S. Fauci in Nature (1995)

  7. No Access

    Article

    Host factors and the pathogenesis of HIV-induced disease

    The level of human immunodeficiency virus (HIV) replication in patients reflects a balance between stimulatory and inhibitory host factors (particularly endogenous cytokines). New information concerning the ce...

    Anthony S. Fauci in Nature (1996)

  8. No Access

    Article

    Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor

    Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) enter target cells by forming a complex between the viral envelope protein and two cell-surface membrane receptors: CD4 and a 7-span t...

    Drew Weissman, Ronald L. Rabin, James Arthos, Andrea Rubbert, Mark Dybul in Nature (1997)

  9. No Access

    Article

    Re-emergence of HIV after stop** therapy

    A dormant reservoir of human immuno-deficiency virus (HIV) is established early on during primary infection1 which consists of latently infected, resting CD4+ T cells carrying replication-competent HIV. This pool...

    Tae-Wook Chun, Richard T. Davey Jr, Delphine Engel, H. Clifford Lane in Nature (1999)

  10. Article

    Biodefence on the research agenda

    The world needs new and creative ways to counter bioterrorism.

    Anthony S. Fauci in Nature (2003)

  11. Article

    The challenge of emerging and re-emerging infectious diseases

    Infectious diseases have for centuries ranked with wars and famine as major challenges to human progress and survival. They remain among the leading causes of death and disability worldwide. Against a constant...

    David M. Morens, Gregory K. Folkers, Anthony S. Fauci in Nature (2004)

  12. Article

    Race against time

    A committed, transparent research effort into the detection, prevention and treatment of bird flu is now critical. Anthony S. Fauci presents the questions that need answers.

    Anthony S. Fauci in Nature (2005)

  13. Article

    25 years of HIV

    Reflecting on how far we have come scientifically since isolating HIV in 1983, Anthony S. Fauci urges a renewed commitment to the far greater challenges ahead, especially that of vaccine development.

    Anthony S. Fauci in Nature (2008)

  14. No Access

    Article

    Early antibody therapy can induce long-lasting immunity to SHIV

    Early administration of broadly neutralizing antibodies in a macaque SHIV infection model is associated with very low levels of persistent viraemia, which leads to the establishment of T-cell immunity and resu...

    Yoshiaki Nishimura, Rajeev Gautam, Tae-Wook Chun, Reza Sadjadpour in Nature (2017)

  15. Article

    Open Access

    Improvement of antibody functionality by structure-guided paratope engraftment

    Broadly neutralizing antibodies (bNAbs) represent a promising alternative to antiretroviral drugs for HIV-1 prevention and treatment. Selected antibodies to the CD4-binding site bolster envelope trimer binding...

    Qingbo Liu, Yen-Ting Lai, Peng Zhang, Mark K. Louder in Nature Communications (2019)

  16. Article

    Combination anti-HIV antibodies provide sustained virological suppression

    Antiretroviral therapy is highly effective in suppressing human immunodeficiency virus (HIV)1. However, eradication of the virus in individuals with HIV has not been possible to date2. Given that HIV suppression ...

    Michael C. Sneller, Jana Blazkova, J. Shawn Justement, Victoria Shi in Nature (2022)